Systematic review and meta-analysis of triclosan-coated sutures for the prevention of surgical-site infection

British Journal of Surgery

Volumn 100, Issue 4, 2013, Pages 465-473

  Wang, Z X ^a,b   Jiang, C P ^a,b   Cao, Y ^a,b   Ding, Y T ^a,b  

^a NANJING UNIVERSITY   (China)

^b Jiangsu Province's Key Medical Centre for Liver Surgery   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873382661     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9062     Document Type: Review

References (62)

1. Barie PS,. Surgical site infections: epidemiology and prevention. Surg Infect (Larchmt) 2002; 3 (Suppl 1): S9-S21.
2. Leaper DJ, van Goor H, Reilly J, Petrosillo N, Geiss HK, Torres AJ, et al., Surgical site infection-a European perspective of incidence and economic burden. Int Wound J 2004; 1: 247-273.
3. Hawn MT, Vick CC, Richman J, Holman W, Deierhoi RJ, Graham LA, et al., Surgical site infection prevention: time to move beyond the surgical care improvement program. Ann Surg 2011; 254: 494-499.
4. Patkar AD, Magee G, Vaughn B, Edmiston CE, Vardireddy N,. The economic burden of surgical site infection using therapeutic antibiotic utilization measure-comparison of two time periods. Value in Health 2010; 13: A432.
5. Alexander JW, Solomkin JS, Edwards MJ,. Updated recommendations for control of surgical site infections. Ann Surg 2011; 253: 1082-1093.
6. Odom-Forren J,. Preventing surgical site infections. Nursing 2006; 36: 58-63.
7. Alexander JW, Kaplan JZ, Altemeier WA,. Role of suture materials in the development of wound infection. Ann Surg 1967; 165: 192-199.
8. Katz S, Izhar M, Mirelman D,. Bacterial adherence to surgical sutures. A possible factor in suture induced infection. Ann Surg 1981; 194: 35-41.
9. Storch ML, Rothenburger SJ, Jacinto G,. Experimental efficacy study of coated VICRYL Plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect (Larchmt) 2004; 5: 281-288.
10. Edmiston CE, Seabrook GR, Goheen MP, Krepel CJ, Johnson CP, Lewis BD, et al., Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination ? J Am Coll Surg 2006; 203: 481-489.
11. Rothenburger S, Spangler D, Bhende S, Burkley D,. In vitro antimicrobial evaluation of coated VICRYL* Plus antibacterial suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect (Larchmt) 2002; 3 (Suppl 1): S79-S87.
12. Ming X, Rothenburger S, Yang D,. In vitro antibacterial efficacy of MONOCRYL Plus antibacterial suture (poliglecaprone 25 with triclosan). Surg Infect (Larchmt) 2007; 8: 201-208.
13. Bojar W, Kazmierska K, Szalwinski M, Zareba T,. Triclosan-coated sutures in oral surgery. Advances in Clinical and Experimental Medicine 2009; 18: 401-405.
14. Marco F, Vallez R, Gonzalez P, Ortega L, De La Lama J, Lopez-Duran L,. Study of the efficacy of coated Vicryl Plus® antibacterial suture in an animal model of orthopedic surgery. Surg Infect (Larchmt) 2007; 8: 359-365.
15. Ming X, Nichols M, Rothenburger S,. In vivo antibacterial efficacy of MONOCRYL Plus antibacterial suture (poliglecaprone 25 with triclosan). Surg Infect (Larchmt) 2007; 8: 209-214.
16. Ming X, Rothenburger S, Nichols MM,. In vivo and in vitro antibacterial efficacy of PDS Plus (polidioxanone with triclosan) suture. Surg Infect (Larchmt) 2008; 9: 451-457.
17. Storch M, Perry LC, Davidson JM, Ward JJ,. A 28-day study of the effect of coated VICRYL* Plus antibacterial suture (coated polyglactin 910 suture with triclosan) on wound healing in guinea pig linear incisional skin wounds. Surg Infect (Larchmt) 2002; 3 (Suppl 1): S89-S98.
18. Storch M, Scalzo H, Van Lue S, Jacinto G,. Physical and functional comparison of coated VICRYL* Plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated VICRYL* suture (coated polyglactin 910 suture). Surg Infect (Larchmt) 2002; 3 (Suppl 1): S65-S77.
19. Fleck T, Moidl R, Blacky A, Fleck M, Wolner E, Grabenwoger M, et al., Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg 2007; 84: 232-236.
20. Justinger C, Schuld J, Sperling J, Kollmar O, Richter S, Schilling MK,. Triclosan-coated sutures reduce wound infections after hepatobiliary surgery-a prospective non-randomized clinical pathway driven study. Langenbecks Arch Surg 2011; 396: 845-850.
21. Rozzelle CJ, Leonardo J, Li V,. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2008; 2: 111-117.
22. Galal I, El-Hindawy K,. Impact of using triclosan-antibacterial sutures on incidence of surgical site infection. Am J Surg 2011; 202: 133-138.
23. Rasic̈ Z, Schwarz D, Adam VN, Sever M, Lojo N, Rasic̈ D, et al., Efficacy of antimicrobial triclosan-coated polyglactin 910 (Vicryl* Plus) suture for closure of the abdominal wall after colorectal surgery. Coll Antropol 2011; 35: 439-443.
24. Baracs J, Huszár O, Sajjadi SG, Horváth OP,. Surgical site infections after abdominal closure in colorectal surgery using triclosan-coated absorbable suture (PDS Plus) vs. uncoated sutures (PDS II): a randomized multicenter study. Surg Infect (Larchmt) 2011; 12: 483-489.
25. DeFazio A, Datta MS, Nezhat C,. Does the use of Vicryl Plus antibacterial suture decrease the incidence of umbilical infection when compared to Vicryl suture ? Fertil Steril 2005; 84 (Suppl 1): S161.
26. Mingmalairak C, Ungbhakorn P, Paocharoen V,. Efficacy of antimicrobial coating suture coated polyglactin 910 with triclosan (Vicryl Plus) compared with polyglactin 910 (Vicryl) in reduced surgical site infection of appendicitis, double blind randomized control trial, preliminary safety report. J Med Assoc Thai 2009; 92: 770-775.
27. Zhang ZT, Zhang HW, Fang XD, Wang LM, Li XX, Li YF, et al., Cosmetic outcome and surgical site infection rates of antibacterial absorbable (polyglactin 910) suture compared to Chinese silk suture in breast cancer surgery: a randomized pilot research. Chin Med J (Engl) 2011; 124: 719-724.
28. Seim BE, Tønnessen T, Woldbaek PR,. Triclosan-coated sutures do not reduce leg wound infections after coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2012; 15: 411-415.
29. Turtiainen J, Saimanen EI, Mäkinen KT, Nykänen AI, Venermo MA, Uurto IT, et al., Effect of triclosan-coated sutures on the incidence of surgical wound infection after lower limb revascularization surgery: a randomized controlled trial. World J Surg 2012; 36: 2528-2534.
30. Chang WK, Srinivasa S, Morton R, Hill AG,. Triclosan-impregnated sutures to decrease surgical site infections: systematic review and meta-analysis of randomized trials. Ann Surg 2012; 255: 854-859.
31. Zhuang CP, Cai GY, Wang YQ,. Comparison of two absorbable sutures in abdominal wall incision. Journal of Clinical Rehabilitative Tissue Engineering Research 2009; 13: 4045-4048.
32. Singh H, Emmert MY, Sakaguchi H, Neng Lee C, Kofidis T,. Antibacterial suture reduces surgical site infections in coronary artery bypass grafting. Heart Surgery Forum 2010; 13: S85.
33. Khachatryan N, Dibirov M, Omelyanovsky V, Chupalov M, Gasanova G,. Prevention of postoperative infections in abdominal surgery using reabsorbable suture with antibacterial activity (Vicryl Plus) versus reabsorbable standard sutures. Surg Infect (Larchmt) 2011; 12: A13-A14.
34. Mattavelli I, Nespoli L, Alfieri S, Cantore F, Sebastian-Douglas S, Cobianchi L, et al., Triclosan-coated suture to reduce surgical site infection after colorectal surgery. Surg Infect (Larchmt) 2011; 12: A14-A15.
35. Williams N, Sweetland H, Goyal S, Ivins N, Leaper DJ,. Randomized trial of antimicrobial-coated sutures to prevent surgical site infection after breast cancer surgery. Surg Infect (Larchmt) 2011; 12: 469-474.
36. Isik I, Selimen D, Senay S, Alhan C,. Efficiency of antibacterial suture material in cardiac surgery: a double-blind randomized prospective study. The Heart Surgery Forum 2012; 15: E40-E45.
37. Moher D, Liberati A, Tetzlaff J, Altman DG,. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 2009; 3: 123-130.
38. ClinicalTrials.gov. http://www.clinicaltrial.gov [accessed 9 May 2012].
39. World Health Organization. International Clinical Trials Registry Platform Search Portal. http://apps.who.int/trialsearch/Default.aspx [accessed 9 May 2012].
40. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. http://www.cochrane-handbook.org [accessed 9 May 2012].
41. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR,. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27: 97-132.
42. The Cochrane Collaboration. Review Manager. Version 5.1.6. The Nordic Cochrane Centre, The Cochrane Collaboration: Copenhagen, 2011.
43. Lau J, Ioannidis JP, Schmid CH,. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820-826.
44. Mantel N, Haenszel W,. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
45. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
46. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
47. Deliaert AE, Van den Kerckhove E, Tuinder S, Fieuws S, Sawor JH, Meesters-Caberg MA, et al., The effect of triclosan-coated sutures in wound healing. A double blind randomised prospective pilot study. J Plast Reconstr Aesthet Surg 2009; 62: 771-773.
48. Ford HR, Jones P, Gaines B, Reblock K, Simpkins DL,. Intraoperative handling and wound healing: controlled clinical trial comparing coated VICRYL Plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated VICRYL suture (coated polyglactin 910 suture). Surg Infect (Larchmt) 2005; 6: 313-321.
49. Masini BD, Stinner DJ, Waterman SM, Wenke JC,. Bacterial adherence to suture materials. J Surg Educ 2011; 68: 101-104.
50. Gristina AG, Price JL, Hobgood CD, Webb LX, Costerton JW,. Bacterial colonization of percutaneous sutures. Surgery 1985; 98: 12-19.
51. Gõmez-Alonso A, García-Criado FJ, Parreño-Manchado FC, García-Sánchez JE, García-Sánchez E, Parreño-Manchado A, et al., Study of the efficacy of coated VICRYL Plus antibacterial suture (coated polyglactin 910 suture with triclosan) in two animal models of general surgery. J Infect 2007; 54: 82-88.
52. Wolcott R, Cutting KF, Dowd SE,. Surgical site infections: biofilms, dehiscence and delayed healing. Wounds UK 2008; 4: 108-113.
53. Glassman JA, Fowler EF, Novak MV,. An experimental study of sulfonamide impregnated sutures. Surg Obstet Gynecol 1944; 78: 359-363.
54. Darouiche RO, Meade R, Mansouri M, Raad II,. In vivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings. J Heart Valve Dis 1998; 7: 639-646.
55. Blaker JJ, Nazhat SN, Boccaccini AR,. Development and characterisation of silver-doped bioactive glass-coated sutures for tissue engineering and wound healing applications. Biomaterials 2004; 25: 1319-1329.
56. Barbolt TA,. Chemistry and safety of triclosan, and its use as an antimicrobial coating on coated VICRYL* Plus antibacterial suture (coated polyglactin 910 suture with triclosan). Surg Infect (Larchmt) 2002; 3 (Suppl 1): S45-S53.
57. Leaper D, Assadian O, Hubner NO, McBain A, Barbolt T, Rothenburger S, et al., Antimicrobial sutures and prevention of surgical site infection: assessment of the safety of the antiseptic triclosan. Int Wound J 2011; 8: 556-566.
58. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC,. Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316: 450-455.
59. Gaynes RP, Culver DH, Horan TC, Edwards JR, Richards C, Tolson JS,. Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis 2001; 33 (Suppl 2): S69-S77.
60. Fry DE,. The economic costs of surgical site infection. Surg Infect (Larchmt) 2002; 3 (Suppl 1): S37-S43.
61. Edmiston CE, Patkar AD, Magee G, Seabrook GR, Vaughn B,. Use of an observational, nationwide inpatient discharge database to document the economic benefits associated with innovative antimicrobial technology to reduce the risk of surgical site infection (SSI). Am J Infect Control 2010; 38: E38.
62. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG,. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20: 271-274.